Dementia Discovery
Startup rounds since 2012 with a Dementia Discovery investor on the board, and the firm's own fund filings.
Raises
28
since 2012
Unannounced
1
no announcement found, of those filed since 2025
Funds
2
fund filings under the firm's name
Rounds
- Endlyz Therapeutics, Inc.$17.3M
- Dualitas Therapeutics, Inc.$32.6M
- Therini Bio, Inc.$74.9M
- 20/20 GeneSystems, Inc.$70K
- TRex Holdings Inc.$42.3M
- Violet Therapeutics, Inc.$7.45M
- Andovia Inc.$632K
- QurAlis Corp$5M
- Endlyz Therapeutics, Inc.$3.25M
- Xilio Therapeutics, Inc.$95M
- Xilio Therapeutics, Inc.$50.2M
- Therini Bio, Inc.$9.36M
- QurAlis Corp$33.2M
- Nitrome Biosciences, Inc$17.1M
- ImmunoMolecular Therapeutics, Inc.$3M
- Veralox Therapeutics Inc.$1.46M
- Sutro Biopharma Inc$85.4M
- Avitide, Inc.$12M
- Arsanis, Inc.$45.5M
- Arsanis, Inc.$15M
- Arsanis, Inc.$4M
- Cervilenz Inc$1.76M
- Avitide, Inc.$3.83M
- Arsanis, Inc.$20M
- Catabasis Pharmaceuticals Inc$12.4M
- Avitide, Inc.$3.44M
- Thesan Pharmaceuticals, Inc.$17.4M
- Cervilenz Inc$2M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 1 | 0 |
| 2025 | 3 | 1 |
| 2024 | 1 | — |
| 2023 | 2 | — |
| 2022 | 1 | — |
| 2021 | 3 | — |
| 2020 | 3 | — |
| 2019 | 2 | — |
| 2018 | 1 | — |
| 2017 | 2 | — |
| 2016 | 1 | — |
| 2015 | 5 | — |
| 2014 | 2 | — |
| 2012 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Dementia Discovery Fund 2 LP | 8 Jan 2025 | $350M | $202M |
| Dementia Discovery LP | 17 Oct 2017 | $302M | $26M |
Listed because a Dementia Discovery fund's filing names a director of each company. A name match is not a verified identity.